Meds A-Z
Febantel
Detailed information about Febantel
Pet Owner Quick Guide
Start here: what this medicine is for, what it does, and when it's usually needed.
Usually used for:
For the removal of tapeworms ( Dipylidium caninum , Taenia pisiformis , Echinococcus granulosus ); hookworms ( Ancylostoma caninum , Uncinaria stenocephala ); ascarids ( Toxocara canis , Toxascaris leonina ); and whipwor...
What it does:
For removal of large strongyles (Strongylus vulgaris S. edentatus, S. equinus); ascarids (Parascaris equorum, sexually mature and immature); pinworms (Oxyuris equi-adult and 4th stage larva); and the various small strong...
When it's needed:
The paste may be administered on the base of the tongue or well mixed into a portion of the normal grain ration. For animals maintained on premises where reinfection is likely to occur, re-treatment may be necessary. For...
Call your vet sooner if you notice:
- The paste may be administered on the base of the tongue or well mixed into a portion of the normal grain ration. For animals maintained on premises where reinfection is likely to occur, re-treatment may be necessary. For most effective results, retreat in 6 to 8 weeks. Not for use in horses intended for food. Consult your veterinarian for assistance in the diagnosis treatment, and control of parasitism. Administer by stomach tube or drench, or by mixing well into a portion of the normal grain ration. For animals maintained on premises where reinfection is likely to occur, re-treatment may be necessary. For most effective results, retreat in 6 to 8 weeks. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Febantel suspension may be used in combination with trichlorfon oral liquid when combining 1 part febantel suspension with 5 parts trichlorfon liquid. Do not use in pregnant animals. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Consider alternative therapy or use with caution in animals with pre-existing liver or kidney dysfunction.
Commonly reported reactions:
- (2 reports)
- (2 reports)
- (1 reports)
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Febantel
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Both
Manufacturer: Elanco US Inc.
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/141007 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/133953 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
The paste may be administered on the base of the tongue or well mixed into a portion of the normal grain ration. For animals maintained on premises where reinfection is likely to occur, re-treatment may be necessary. For most effective results, retreat in 6 to 8 weeks. Not for use in horses intended for food. Consult your veterinarian for assistance in the diagnosis treatment, and control of parasitism. Administer by stomach tube or drench, or by mixing well into a portion of the normal grain ration. For animals maintained on premises where reinfection is likely to occur, re-treatment may be necessary. For most effective results, retreat in 6 to 8 weeks. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Febantel suspension may be used in combination with trichlorfon oral liquid when combining 1 part febantel suspension with 5 parts trichlorfon liquid. Do not use in pregnant animals. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Consider alternative therapy or use with caution in animals with pre-existing liver or kidney dysfunction.
- High: The paste may be administered on the base of the tongue or well mixed into a portion of the normal grain ration. For animals maintained on premises where reinfection is likely to occur, re-treatment may be necessary. For most effective results, retreat in 6 to 8 weeks. Not for use in horses intended for food. Consult your veterinarian for assistance in the diagnosis treatment, and control of parasitism. Administer by stomach tube or drench, or by mixing well into a portion of the normal grain ration. For animals maintained on premises where reinfection is likely to occur, re-treatment may be necessary. For most effective results, retreat in 6 to 8 weeks. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Febantel suspension may be used in combination with trichlorfon oral liquid when combining 1 part febantel suspension with 5 parts trichlorfon liquid. Do not use in pregnant animals. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Consider alternative therapy or use with caution in animals with pre-existing liver or kidney dysfunction.
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Most Reported Reactions
| Reaction | Cases | Species | Serious cases |
|---|---|---|---|
| 2 | Cat, Dog | 1 | |
| 2 | Cat, Dog | 0 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 |
Species coverage: Cat (18) Dog (14)
View detailed reaction table
| Reaction | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - |
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2024-US-023077
Storage & Handling
No storage/handling guidance is linked yet.
Documents
Official label facts are separated from secondary summaries.
Official documents: 16 • Secondary summaries: 0
- ucm116081.pdf · FOI
- ucm116050.pdf · FOI
- N141007_Supp_03-28-1996.pdf · FOI
- N141007_Orig_5_19_1994.pdf · FOI
- Drontal™ Plus Taste Tabs™ · SPL
- Drontal™ Plus · SPL
- Quad Dewormer · SPL
- N133953_Supp_09_12_1991.pdf · FOI
- Vercom Paste Anthelmintic · SPL
- Negabot Plus Paste · SPL
- Combotel · SPL
- Rintal® Paste · SPL
- Cutter Paste · SPL
- Rintal® Suspension · SPL
- UCM478240.pdf · FOI
- Rintal® Tabs Anthelmintic Tablets · SPL
No source yet.
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/557 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/556 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/2505 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/3619 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1392/Drontal%E2%84%A2%20Plus%20Taste%20Tabs%E2%84%A2 · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1391/Drontal%E2%84%A2%20Plus · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1393/Quad%20Dewormer · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1635 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2047/Vercom%20Paste%20Anthelmintic · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/540/Negabot%20Plus%20Paste · document · SPL
Promotional Materials (Marketing)
This content is marketing material and not clinical guidance.
No marketing assets are linked yet.
No source yet.
Technical appendix (vet reference)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
- Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 10:44 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Feb 16, 2026, 11:02 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 12, 2026, 10:42 PM UTC
Diagnosis-code mappings are not available for this medication yet.
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
- The paste may be administered on the base of the tongue or well mixed into a portion of the normal grain ration. For animals maintained on premises where reinfection is likely to occur, re-treatment may be necessary. For most effective results, retreat in 6 to 8 weeks. Not for use in horses intended for food. Consult your veterinarian for assistance in the diagnosis treatment, and control of parasitism. Administer by stomach tube or drench, or by mixing well into a portion of the normal grain ration. For animals maintained on premises where reinfection is likely to occur, re-treatment may be necessary. For most effective results, retreat in 6 to 8 weeks. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Febantel suspension may be used in combination with trichlorfon oral liquid when combining 1 part febantel suspension with 5 parts trichlorfon liquid. Do not use in pregnant animals. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Consider alternative therapy or use with caution in animals with pre-existing liver or kidney dysfunction. (Contraindication, High)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 30798-201-63 | 30798 | - | |
| 30798-202-61 | 30798 | - | |
| 30798-203-61 | 30798 | - | |
| 52133-0047-0 | 52133 | - | |
| 58198-0056-1 | 58198 | - | |
| 58198-0056-2 | 58198 | - | |
| 58198-0057-1 | 58198 | - | |
| 58198-0057-2 | 58198 | - | |
| 58198-0058-1 | 58198 | - | |
| 58198-0058-2 | 58198 | - | |
| 58198-0065-1 | 58198 | - | |
| 58198-0066-1 | 58198 | - | |
| 58198-0067-1 | 58198 | - | |
| 58198-0068-1 | 58198 | - | |
| 58198-0069-1 | 58198 | - | |
| 58198-0070-1 | 58198 | - | |
| 62157-442-01 | 62157 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
N141007_Orig_5_19_1994.pdf
• FOI summary • Official
• June 15, 2022
FDA FOI summary for application 141007
-
N141007_Supp_03-28-1996.pdf
• FOI summary • Official
• June 15, 2022
FDA FOI summary for application 141007
-
ucm116050.pdf
• FOI summary • Official
• June 15, 2022
FDA FOI summary for application 141007
-
ucm116081.pdf
• FOI summary • Official
• June 15, 2022
FDA FOI summary for application 141007
-
N133953_Supp_09_12_1991.pdf
• FOI summary • Official
• July 10, 2017
FDA FOI summary for application 133953
-
UCM478240.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 140912
Data Sources & Revision History
Every non-trivial field is expected to include provenance and update timestamps.
- contraindications: The paste may be administered on the base of the tongue or well mixed into a portion of the normal grain ration. For animals maintained on premises where reinf… (Official, 2026-02-12)
- side_effects: Top reported reactions (openFDA): Vomiting, Emesis (multiple), Emesis, Diarrhoea, Lack of efficacy (endoparasite) - tapeworm, Lethargy (see also Central nervou… (Official, 2026-02-12)
- usage: For removal of large strongyles (Strongylus vulgaris S. edentatus, S. equinus); ascarids (Parascaris equorum, sexually mature and immature); pinworms (Oxyuris … (Official, 2026-02-12)
- side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
Drontal™ Plus Taste Tabs™ Drontal™ Plus Quad Dewormer
RX
Febantel Praziquantel Pyrantel Pamoate
Tablet
• Oral
|
Elanco US Inc. | NADA 141-007 | Approved | Jun 15, 2022 |
|
Vercom Paste Anthelmintic
RX
Febantel Praziquantel
Paste
• Oral
|
Elanco US Inc. | NADA 133-953 | Approved | Jul 10, 2017 |
|
Negabot Plus Paste Combotel
OTC
Febantel Trichlorfon
|
Bayer HealthCare LLC, Animal Health Division | NADA 131-412 | W | Jun 1, 2016 |
|
Rintal® Paste Cutter Paste
OTC
Febantel
Paste
• Oral
|
Elanco US Inc. | NADA 107-345 | Approved | Jun 1, 2016 |
|
Rintal® Suspension
OTC
Febantel
Liquid (Suspension)
• Nasogastric, Oral
|
Elanco US Inc. | NADA 107-346 | Approved | Jun 1, 2016 |
|
Rintal® Tabs Anthelmintic Tablets
RX
Febantel
Tablet
• Oral
|
Elanco US Inc. | NADA 140-912 | Approved | Jun 1, 2016 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
1) 22.7 milligrams praziquantel, 22.7 milligrams pyrantel base, and 113.4 milligrams febantel
2) 68 milligrams praziquantel, 68 milligrams pyrantel base, and 340.2 milligrams febantel
or
3) 136 milligrams praziquantel, 136 milligrams pyrantel base, and 680.4 milligrams febantel
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
-
FOI ucm116081.pdf
Summary
This supplement amends the approved NADA by adding a flavored tablet formulation with the same indications. -
FOI ucm116050.pdf
Summary
Effect of Supplement: This supplement amends the NADA to provide for a larger tablet containing 136.0 mg praziquantel, 136.0 mg pyrantel base as pyrantel pamoate and 680.4 mg febantel and the associated label changes. -
Summary
This supplemental application amends NADA 141-007, Drontal™ Plus Broad Spectrum Anthelmintic Tablets, by adding the tape-worm Echinococcus multilocularis claim to the label.
-
Summary
Drontalâ¿¢ Plus Broad Spectrum Anthelmintic Tablets are indicated for the removal of the following intestinal parasites in dogs:
Tapeworms (Dipylidium caninum, Taenia pisiformis, Echinococcus granulosus)
Hookworms (Ancylostoma caninum, Incinaria stenocephala)
Ascarids (Toxocara canis, Toxascaris leonina)
Whipworms (Trichuris vulpis)
- Drontal™ Plus Taste Tabs™ (ZIP)
- Drontal™ Plus (ZIP)
- Quad Dewormer (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
This supplement provides for the addition of the following warning statement to the label: "Warning: Consider alternative therapy or use with caution in animals with pre-existing liver or kidney dysfunction."
FDA page: Open in Animal Drugs @ FDA
- Negabot Plus Paste (ZIP)
- Combotel (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Rintal® Paste (ZIP)
- Cutter Paste (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Rintal® Suspension (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM478240.pdf
Summary
Rintal® Tabs Anthelmintic Tablets are indicated for the removal of the following nematode parasites: In Dogs and Puppies: Hookworms (Ancylosotoma caninum, Uncinaria stenocephala); Ascarids (Toxocara canis, Toxascaris leonina); Whipworms (Trichuris vulpis). In Cats and Kittens: Hookworms (ancylostoma tubaeforme); Ascarids (Toxocara cati).
FDA page: Open in Animal Drugs @ FDA
Usage
For removal of large strongyles (Strongylus vulgaris S. edentatus, S. equinus); ascarids (Parascaris equorum, sexually mature and immature); pinworms (Oxyuris equi-adult and 4th stage larva); and the various small strongyles in horses, foals, and ponies. For removal of ascarids (Parascaris equorum, adult and sexually immature), pinworms (Oxyuris equi-adult and 4th stage larvae), large strongyles (Strongylus vulgaris, S. edentatus, S. equinus), and the various small strongyles in horses, breeding stallions and mares, pregnant mares, foals, and ponies. For removal of hookworms (Ancylostoma caninum and Uncinaria stenocephala), whipworms (Trichuris vulpis), ascarids (Toxocara canis and Toxascaris leonina), and tapeworms (Dipylidium caninum and Taenia pisiformis).
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
The paste may be administered on the base of the tongue or well mixed into a portion of the normal grain ration. For animals maintained on premises where reinfection is likely to occur, re-treatment may be necessary. For most effective results, retreat in 6 to 8 weeks. Not for use in horses intended for food. Consult your veterinarian for assistance in the diagnosis treatment, and control of parasitism. Administer by stomach tube or drench, or by mixing well into a portion of the normal grain ration. For animals maintained on premises where reinfection is likely to occur, re-treatment may be necessary. For most effective results, retreat in 6 to 8 weeks. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Febantel suspension may be used in combination with trichlorfon oral liquid when combining 1 part febantel suspension with 5 parts trichlorfon liquid. Do not use in pregnant animals. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Consider alternative therapy or use with caution in animals with pre-existing liver or kidney dysfunction.
Side Effects
No approved side-effect narrative is linked yet.
openFDA reaction signals are available for Dog 56 and Cat 8 (view top reported reactions).
Top Reported Reactions (openFDA)
Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Dog, Newfoundland, Female, 10.66 year, 61.24 kilogram • Drug: MSK, Tablet, Oral, Dose: 2.25 tablet per animal • Reactions: Death • Outcome: Died
- Report ID: USA-USFDACVM-2025-US-056128
- Serious AE: Yes
- Treated For AE: No
- Sex: Female
- Age: 10.66 Year
- Weight: 61.240 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
- Dose: 2.25 tablet per animal
Dog, Crossbred Canine/dog, Female, 3 month, 15.195 kilogram • Drug: MSK, Tablet, Oral • Reactions: Lack of efficacy (endoparasite) - hookworm, Other abnormal test result NOS • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-055641
- Serious AE: No
- Treated For AE: Yes
- Sex: Female
- Age: 3.00 Month
- Weight: 15.195 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
Dog, Retriever - Labrador, Female, 2.5 year, 26.21 kilogram • Drug: MSK, Tablet, Unknown • Reactions: Lack of efficacy (endoparasite) - hookworm, Other abnormal test result NOS • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-055796
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 2.50 Year
- Weight: 26.210 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Tablet
Dog, Dog (unknown), Female, 13 week • Drug: MSK, Tablet, Oral • Reactions: Vomiting • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-055397
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 13.00 Week
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
Dog, Bulldog - French, Male, 8 year, 13.88 kilogram • Drug: MSK, Tablet, Oral, Dose: 1.50 tablet per animal, Frequency: 1 per day • Reactions: Soft stool, Vomiting, Loss of appetite, Inappropriate urination, Discomfort NOS… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-054237
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 8.00 Year
- Weight: 13.880 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
- Dose: 1.50 tablet per animal
- Frequency: 1 per day
Dog, Pit Bull, Male, 10 week, 3.175 kilogram • Drug: MSK, Tablet, Oral, Dose: 3 tablet per animal • Reactions: Bloated stomach, Decreased activity, Overdose • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-054129
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 10.00 Week
- Weight: 3.175 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
- Dose: 3 tablet per animal
Cat, Cat (unknown), Male, 3.85 kilogram • Drug: MSK, Tablet, Oral, Dose: 1 tablet per animal • Reactions: Tiredness (lethargy), Vomiting, Distension of abdomen, Not himself/herself, Not drinking… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-034225
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Weight: 3.850 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
- Dose: 1 tablet per animal
Cat, Domestic Shorthair, Female, 2 year, 3.31 kilogram • Drug: MSK, Tablet, Oral, Dose: 1 tablet per animal • Reactions: Tiredness (lethargy), Partial anorexia, Administration error NOS • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-022017
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 2.00 Year
- Weight: 3.310 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
- Dose: 1 tablet per animal
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.